NASDAQ · Medical - Devices

Accuray Incorporated (ARAY) Stock

$0.13 -2.91% NASDAQ: ARAY Healthcare

Valuation

MetricValue
Price$0.13
Market Cap$15.54M
P/E Ratio-0.71
P/B Ratio0.83
P/S Ratio0.08
EPS (TTM)$0.00
52-Week High$2.10
52-Week Low$0.13
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-99.04%
ROA-11.09%
ROCE-10.48%
Gross Margin1.74%
Operating Margin1.74%
Net Margin-12.24%
Debt/Equity4.41
Current Ratio1.64

Annual Financials (USD)

Metric20222023202420252026
Revenue$430.0M$448.0M$447.0M$459.0M$402.0M
Operating Profit$8.0M$2.0M$1.0M$8.0M$-26.0M
Net Profit$-5.0M$-9.0M$-16.0M$-2.0M$-49.0M
EPS$-0.06$-0.10$-0.16$-0.02$-0.40
Op Margin1.9%0.5%0.1%1.7%-6.6%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$473.0M$479.0M$469.0M$470.0M$444.0M
Total Liabilities$420.0M$426.0M$424.0M$389.0M$402.0M
Cash$89.0M$89.0M$69.0M$57.0M$41.0M
Borrowings$199.0M$205.0M$211.0M$176.0M$184.0M

Latest News

Accuray (ARAY) Stock Sees Fair Value Cut After Downgrades And Lower Growth Assumptions Simply Wall St. · Jun 27, 2026 Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules PR Newswire · May 29, 2026 Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer PR Newswire · May 15, 2026 Accuray Inc (ARAY) Runs Into Middle East Headwinds, But Shift Plan Is Working Insider Monkey · May 12, 2026 Toast downgraded, Lowe's upgraded: Wall Street's top analyst calls The Fly · May 12, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$-2.0M$16.0M$-12.0M$3.0M$-7.0M
Investing Cash Flow$-9.0M$-25.0M$-7.0M$-17.0M$-18.0M
Financing Cash Flow$0$0$0$-13.0M$0
Net Cash Flow$-28.0M$1.0M$-21.0M$-8.0M$-13.0M
Free Cash Flow$-7.0M$3.0M$-16.0M$-6.0M$-13.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-12.32
FCF Yield-41.51%
Quick Ratio0.74
Interest Coverage-0.75
Return 1Y-79.42%
Return 3Y-92.80%
Return 5Y-93.21%

Ownership

Insiders Held4.35%
Institutions Held69.38%
Institutions Float Held72.53%
Institutional HolderSharesReport Date
TCW Group, Inc.15,467,9522026-03-31
Blackrock Inc.8,458,4092026-03-31
Neuberger Berman Group, LLC5,855,0642026-03-31
Armistice Capital, LLC5,636,0002026-03-31
Weber Capital Management LLC /ADV5,055,2942026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANIKAnika Therapeutics Inc. $21.42 +1.56% -70.87 $286.66M 0.00%
AVRAnteris Technologies Global Corp. $5.87 -2.17% -2.74 $572.08M 0.00%
LNSRLENSAR, Inc. $6.07 +0.83% 5.25 $74.58M 0.00%
MISTMilestone Pharmaceuticals Inc. $0.65 -7.76% -1.17 $80.70M 0.00%
MXCTMaxCyte, Inc. $1.40 -2.10% -3.20 $144.49M 0.00%

About Accuray Incorporated

Accuray Incorporated is led by CEO Stephen R. LaNeve, employs 987 people, headquartered in US, publicly traded since 2007.

Accuray Incorporated (ARAY) stock trades at $0.13 with a market capitalization of $15.54M. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.71, reflecting a net loss over the last twelve months, price-to-book of 0.83, price-to-sales of 0.08. Over the past 52 weeks the stock has ranged between $0.13 and $2.10, and currently trades 93.8% below its 52-week high.

On profitability, Accuray Incorporated generates a return on equity (ROE) of -99.04% (negative, reflecting a net loss), return on capital employed of -10.48%, an operating margin of 1.74%, a net profit margin of -12.24%.

Accuray Incorporated by the numbers, 2017–2026

Between 2017 and 2026 Accuray Incorporated reported revenue of $383.0M rising to $402.0M, a change of +5.0% across 10 years. Compounded, revenue has grown 0.3% a year over five years, -3.5% over three, -12.4% over the last twelve months. Net profit fell to $-49.0M.

Operating margin went from -2.6% in 2017 to -6.6% in 2026, a fall of 4.0 percentage points. The most recent net margin is -12.24%. On a trailing twelve-month basis to Jun '26, revenue is $402.0M and net profit $-50.0M.

Borrowings rose from $165.0M to $184.0M, cash from operations was $-7.0M in the latest year, positive in 4 of the last 10.

Return on equity has averaged -36.2% over five years, and was -116.7% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Accuray Incorporated (ARAY) — frequently asked questions

What is Accuray Incorporated (ARAY) stock price today?

Accuray Incorporated (ARAY) is currently trading at $0.13, down 2.91% today.

What is ARAY P/E ratio?

Accuray Incorporated's P/E ratio is -0.71. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is ARAY return on equity (ROE)?

Accuray Incorporated's return on equity (ROE) is -99.04%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is Accuray Incorporated's market cap?

Accuray Incorporated has a market capitalization of $15.54M.

Does ARAY pay a dividend?

Accuray Incorporated is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does ARAY carry?

Accuray Incorporated has a debt-to-equity ratio of 4.41. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is ARAY's profit margin?

Accuray Incorporated reports a net profit margin of -12.24% — the share of revenue left after every cost, including tax and interest.

What sector is ARAY in?

Accuray Incorporated is classified under Healthcare, in the Medical - Devices industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is ARAY listed on?

Accuray Incorporated trades on NASDAQ under the ticker ARAY.

What is ARAY's 52-week range?

Over the last year Accuray Incorporated has traded between $0.13 and $2.10.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens ARAY currently matches

On the figures above, Accuray Incorporated passes the filters for 3 of our ready-made screens, among them Penny Stocks, Stocks Under $1, Nano Cap Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Penny StocksStocks Under $1Nano Cap Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.